Guardian Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- Guardian Pharmacy's estimated annual revenue is currently $120.6M per year.
- Guardian Pharmacy's estimated revenue per employee is $283,750
Employee Data
- Guardian Pharmacy has 425 Employees.
- Guardian Pharmacy grew their employee count by 7% last year.
Guardian Pharmacy's People
Name | Title | Email/Phone |
---|
Guardian Pharmacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 18 | -28% | N/A | N/A |
#2 | $58.4M | 234 | 9% | N/A | N/A |
#3 | $100.7M | 355 | 13% | N/A | N/A |
#4 | $318.4M | 1002 | N/A | N/A | N/A |
#5 | $13.1M | 64 | 36% | N/A | N/A |
#6 | $7.8M | 43 | 0% | N/A | N/A |
#7 | $89.1M | 314 | 3% | N/A | N/A |
#8 | $2.2M | 16 | 23% | N/A | N/A |
#9 | $27.2M | 120 | N/A | N/A | N/A |
#10 | $8.9M | 49 | 32% | N/A | N/A |
What Is Guardian Pharmacy?
Independently owned and operated since 1964, Guardian® pharmacies are run by pharmacists who pride themselves on keeping their communities healthy.
keywords:N/AN/A
Total Funding
425
Number of Employees
$120.6M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Guardian Pharmacy News
His body was found the next morning and there was no sign of his asthma medication being with him. Pharmacy records revealed that in the last...
His body was found the next morning and there was no sign of his asthma medication being with him. Pharmacy records revealed that in the last...
Britain's prime minister pointedly described India as the world's pharmacy. Mr Johnson, who faces political oblivion thanks to his own...
Britain's prime minister pointedly described India as the world's pharmacy. Mr Johnson, who faces political oblivion thanks to his own...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $150.2M | 445 | 7% | N/A |
#2 | $58.3M | 466 | 4% | N/A |
#3 | $192.6M | 467 | N/A | N/A |
#4 | N/A | 470 | 27% | N/A |
#5 | $35M | 501 | N/A | N/A |